ArticleTherapeutic advances in musculoskeletal disease2022

Comparison of the efficacy and risk of discontinuation between non-TNF-targeted treatment and a second TNF inhibitor in patients with rheumatoid arthritis after first TNF inhibitor failure.

Dong-Jin Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.